Table S3 from Phase II Trial of Ipilimumab with Stereotactic Radiation Therapy for Metastatic Disease: Outcomes, Toxicities, and Low-Dose Radiation–Related Abscopal Responses
James W. Welsh(The University of Texas MD Anderson Cancer Center), David S. Hong(The University of Texas MD Anderson Cancer Center), Aung Naing(The University of Texas MD Anderson Cancer Center), Kelvin C. P. Wang(Western Transportation Institute), Joe Y. Chang(The University of Texas MD Anderson Cancer Center), Vassiliki A. Papadimitrakopoulou(Pfizer (United States)), Chad Tang(The University of Texas MD Anderson Cancer Center), Patricia M. de Groot, Erminia Massarelli(The University of Texas MD Anderson Cancer Center), Adi Diab(Cleveland Clinic), Vivek Subbiah(Sarah Cannon), James P. Allison(The University of Texas MD Anderson Cancer Center), John V. Heymach(The University of Texas MD Anderson Cancer Center), Daniel R. Gomez(Cedars-Sinai Medical Center), Ritsuko Komaki(The University of Texas MD Anderson Cancer Center), Rishab Ramapriyan(Brigham and Women's Hospital), Padmanee Sharma(The University of Texas MD Anderson Cancer Center), Hampartsoum B. Barsoumian(The University of Texas MD Anderson Cancer Center), Vivek Verma(Christ University), Q.N. Nguyen, Ramona Dadu(The University of Texas MD Anderson Cancer Center), Maria E. Cabanillas(The University of Texas MD Anderson Cancer Center), George R. Simon(Ohio Department of Health), Stephen Hahn, S. Shaaban, Hari Menon(Tata Memorial Hospital), Uma Raju, Clark L. Anderson(The University of Texas at San Antonio Health Science Center), Taylor R. Cushman, María Angélica Cortez(The University of Texas MD Anderson Cancer Center), Kenneth R. Hess(The University of Texas MD Anderson Cancer Center)
Cited by 0
Related Papers
Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline
|Journal of Clinical Oncology|2018|3.7k
Osimertinib or Platinum–Pemetrexed in <i>EGFR</i> T790M–Positive Lung Cancer
|New England Journal of Medicine|2016|3.3k
Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma
|Cell|2016|2.4k
Melanoma staging: Evidence‐based changes in the American Joint Committee on Cancer eighth edition cancer staging manual
|CA A Cancer Journal for Clinicians|2017|2.3k
Immunologic Correlates of the Abscopal Effect in a Patient with Melanoma
|New England Journal of Medicine|2012|2.1k